Literature DB >> 12620704

Diastolic blood pressure is the first to rise in association with early subclinical obstructive sleep apnea: lessons from periodic examination screening.

Yehonatan Sharabi1, Alon Scope, Natasha Chorney, Itamar Grotto, Yaron Dagan.   

Abstract

BACKGROUND: Obstructive sleep apnea syndrome (OSAS) is associated with long-term cardiovascular morbidity. Little is known about these relations at early stages. We conducted a case-control study in which we analyzed the clinical characteristics of young adults who underwent a periodic health examination and were screened for, and eventually found to experience, OSAS.
METHODS: We identified 121 subjects newly diagnosed in a sleep study as having OSAS, and 229 matched control subjects in which screening for OSAS was negative. All had a medical interview, physical examination, and routine laboratory tests.
RESULTS: Subjects who had OSAS had a higher, body mass index (3-kg/m(2) difference) and a higher diastolic blood pressure (4-mm Hg difference) value, without elevation in systolic blood pressure. There was no metabolic difference (lipids profile and fasting glucose levels) between groups.
CONCLUSIONS: Diastolic blood pressure is higher early in the course of OSAS. Long term follow-up may determine effects of prevention and early intervention in OSAS and associated hypertension.

Entities:  

Mesh:

Year:  2003        PMID: 12620704     DOI: 10.1016/s0895-7061(02)03250-8

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  9 in total

1.  Will wearing dentures affect edentulous patients' breathing during sleep?

Authors:  Qiuwen Chen; Dong Zou; Hailan Feng; Shaoxia Pan
Journal:  Sleep Breath       Date:  2017-01-14       Impact factor: 2.816

2.  Effects of continuous positive airway pressure on blood pressure and daytime sleepiness in obstructive sleep apnea patients with coronary heart diseases under optimal medications.

Authors:  Qing Zhao; Zhi-Hong Liu; Qin Luo; Zhi-Hui Zhao; Hong-Liang Zhang; Yong Wang
Journal:  Sleep Breath       Date:  2011-02-22       Impact factor: 2.816

3.  Association of Adenotonsillectomy With Blood Pressure Among Hypertensive and Nonhypertensive Children With Obstructive Sleep Apnea.

Authors:  Cho-Hsueh Lee; Kun-Tai Kang; Shuenn-Nan Chiu; I-Sheng Chang; Wen-Chin Weng; Pei-Lin Lee; Wei-Chung Hsu
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-04-01       Impact factor: 6.223

Review 4.  OSA: the new cardiovascular disease: part II: Overview of cardiovascular diseases associated with obstructive sleep apnea.

Authors:  Kiran Devulapally; Raymond Pongonis; Rami Khayat
Journal:  Heart Fail Rev       Date:  2008-08-29       Impact factor: 4.214

5.  Hypertension and catecholamine levels in sleep apnoea.

Authors:  Vasu Vardhan; K Shanmuganandan
Journal:  Med J Armed Forces India       Date:  2012-01-18

6.  Association of Obstructive Sleep Apnea With Nighttime Blood Pressure in African Americans: The Jackson Heart Study.

Authors:  Stephen Justin Thomas; Dayna A Johnson; Na Guo; Marwah Abdalla; John N Booth; Tanya M Spruill; Chandra L Jackson; Yuichiro Yano; Mario Sims; David Calhoun; Paul Muntner; Susan Redline
Journal:  Am J Hypertens       Date:  2020-10-21       Impact factor: 3.080

7.  The association between the phenotype of excessive daytime sleepiness and blood pressure in patients with obstructive sleep apnea-hypopnea syndrome.

Authors:  Qimin Wang; Cheng Zhang; Peng Jia; Jing Zhang; Liping Feng; Shumin Wei; Yiping Luo; Li Su; Can Zhao; Hui Dong; Jing Ma; Guangfa Wang
Journal:  Int J Med Sci       Date:  2014-05-09       Impact factor: 3.738

Review 8.  Obstructive sleep apnea syndrome (OSAS) and hypertension: pathogenic mechanisms and possible therapeutic approaches.

Authors:  Wang Zhang; Liang-yi Si
Journal:  Ups J Med Sci       Date:  2012-09-25       Impact factor: 2.384

9.  Cardiovascular Consequences of Repetitive Arousals over the Entire Sleep Duration.

Authors:  Yanyan Wu; Rong Huang; Xu Zhong; Yi Xiao
Journal:  Biomed Res Int       Date:  2017-09-05       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.